Neuropeptides and neuronal survival: neuroprotective strategy for Alzheimer's disease.
Gozes
I
I
Department of Clinical Biochemistry, Sackler School of Medicine, Tel Aviv University, Israel.
Bardea
A
A
Bechar
M
M
Pearl
O
O
Reshef
A
A
Zamostiano
R
R
Davidson
A
A
Rubinraut
S
S
Giladi
E
E
Fridkin
M
M
Brenneman
D E
DE
D000281:Administration, Intranasal; D000544:Alzheimer Disease / Q000188:drug therapy / Q000473:pathology / Q000517:prevention & control*; D000818:Animals; D016923:Cell Death / Q000187:drug effects; D006801:Humans; D066298:In Vitro Techniques; D007858:Learning / Q000187:drug effects; D008568:Memory / Q000187:drug effects; D009474:Neurons / Q000187:drug effects* / Q000473:pathology; D009479:Neuropeptides / Q000494:pharmacology* / Q000502:physiology*; D051381:Rats; D014660:Vasoactive Intestinal Peptide / Q000008:administration & dosage / Q000494:pharmacology / Q000502:physiology
D009479:Neuropeptides; C086770:stearyl-norleucine(17)-vasoactive intestinal peptide; D014660:Vasoactive Intestinal Peptide